NCT05539677Recruiting
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
Analysis of the Immunogenetic Profile of Patients With Aggressive Course of Malignant Neoplastic Process Resistant to the Standard Treatment Approaches: a Translational Study
Source: ClinicalTrials.gov · Last updated 6 May 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The investigators will collect biosamples of patient blood and tumour tissue for further immunological analysis of blood cell subpopulations, immunosupressive factors concentration, HLA expression an lymphocytes and tumour tissue, and and cancer testis antigenes expression on tumour cells, as well as clinical data on patient's stage, therapy, response and demographics. Possible prognostic and predictive dynamic biomarkers will be discovered for individualisation of treatment strategies
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 4 Sept 2022
- Start date
- 1 Sept 1998
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- N.N. Petrov National Medical Research Center of Oncology
- NCT number
- NCT05539677
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Sept 1998 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent Lymphoprolipherative disorder
- Patients receiving immunosupressive therapy for concurrent illness
Other illness
- Incomplete informaton on previous cancer history or medical history
Other
- Patients after stem cell or bone marrow thansplantation
- Patients with known primary immunodeficiency
- Pregnant patients
Who the study is looking for
- Signed inform consent
- Histolgically verified solid tumour
- Receiving systemic therapy for neoplasm
- Has archival tumour tissue
- Provide biosamples with living tumour tissue or blood samples for immunologic assessment
Age in the registry: 1 year to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| N.N. Petrov NMRC of Oncology, Oncoimmunology dep. Coordinator of this site? Confirm its status | Saint Petersburg | Russia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.